ProductProductWhat are Generics?
Diovan
view photo
Generic Diovan Valsartan 40/80/160mg

Generic Diovan is used for treating high blood pressure alone or with other medicines. It is also used for treating heart failure in patients who do not tolerate angiotensin-converting enzyme (ACE) inhibitors.


Hypertension, Cardiovascular Diseases


PackagePricePer pillSavingsOrder
40mg × 30 pills$45.00$ 1.50 
40mg × 60 pills$85.00$ 1.42  $5.00
40mg × 90 pills$115.00$ 1.28  $20.00
40mg × 120 pills$145.00$ 1.21  $35.00
40mg × 180 pills$216.00$ 1.20  $54.00
PackagePricePer pillSavingsOrder
80mg × 30 pills$55.00$ 1.83 
80mg × 60 pills$105.00$ 1.75  $5.00
80mg × 90 pills$145.00$ 1.61  $20.00
80mg × 120 pills$185.00$ 1.54  $35.00
80mg × 180 pills$255.00$ 1.42  $75.00
PackagePricePer pillSavingsOrder
160mg × 30 pills$61.13$ 2.04 
160mg × 60 pills$117.51$ 1.96  $4.75
160mg × 90 pills$173.95$ 1.93  $9.44
160mg × 120 pills$228.85$ 1.91  $15.67
PRODUCT DESCRIPTION Show Product Info
Search for pillsSearch for pills

TestimonialsTestimonials
Thank-you for your service, everything has arrived without any hiccups
Read more »Read more »
NewsNews
    Medtronic procedure to control hypertension - Pioneer Press
    Medtronic procedure to control hypertensionPioneer PressThe procedure could also pare down expenditures for hypertension drugs, led by Novartis AG's Diovan, which totaled $13
    Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market ... - Sacramento Bee
    Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market
    Novartis to Buy Fougera for $1.5 Billion for Skin Drugs - Bloomberg
    BloombergNovartis to Buy Fougera for $1
    Novartis Sues Lupin, Torrent Over Blood-Pressure Medicine - Bloomberg
    Novartis Sues Lupin, Torrent Over Blood-Pressure MedicineBloombergNovartis, based in Basel, Switzerland, is counting on new products, including Exforge, to help replace revenue lost when the company's best sellers, Diovan for hypertension and Gleevac for leukemia, start to lose US patent protection later this year
    The Market is WRONG About This Well-Known Pharma Stock - StreetAuthority
    The Market is WRONG About This Well-Known Pharma StockStreetAuthorityIts $5
Live support Online Chat


Our billing is certified by
Secure shopping certificates